Healthcare Services

Atopic Dermatitis Industry Expansion Forecast Showing Market Size of $19.53 Billion by 2030 at 14.6% CAGR

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Atopic Dermatitis Market Expected To Change Between 2026 And 2030?

The atopic dermatitis market has seen substantial growth recently. This market is anticipated to expand from $9.88 billion in 2025 to $11.34 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The historical increase in the market can be attributed to factors like the rising occurrence of chronic skin conditions, improved access to topical corticosteroids, the broadening of dermatology care services, increased understanding of eczema management, and enhanced accuracy in diagnosis.

The atopic dermatitis market is projected to experience swift expansion over the coming years, with its value set to reach $19.53 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.6%. This anticipated growth can be attributed to the greater uptake of biologics and JAK inhibitors, an intensified focus on customized dermatology treatments, the broadening availability of injectable therapies, an increase in investment dedicated to dermatology research, and a heightened need for sustained symptom management. Furthermore, key trends during this projection period encompass a surge in the use of biologic therapies, an escalating demand for targeted immunomodulators, a strengthened commitment to continuous disease management, the development of sophisticated topical formulations, and a greater emphasis on treatments centered around the patient.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

What Drivers Are Expected To Influence The Atopic Dermatitis Market During The Forecast Period?

The rising need for personalized medicine is projected to stimulate the expansion of the atopic dermatitis market. Personalized medicine represents an advanced method in healthcare and medical treatment that adapts medical decisions, practices, interventions, and drug therapies to the unique requirements of each patient. In the context of atopic dermatitis, this approach involves pinpointing specific genetic and molecular elements that influence the condition, thereby enabling the development of targeted therapies designed to address the individual characteristics of every patient. This methodology not only boosts the efficacy of treatment but also lessens adverse reactions. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group dedicated to tailored medical treatments, announced that the FDA sanctioned 16 new personalized treatments for rare disease patients in 2023, a significant rise from six in 2022. Therefore, the increasing demand for personalized medicine is fueling the growth of the atopic dermatitis market.

How Is The Atopic Dermatitis Market Structured Across Different Segments?

The atopic dermatitis market covered in this report is segmented –

1) By Drug Class: Corticosteroids, Emollients Or Moisturizers, IL-4 And PDE4 Inhibitors, Calcineurin Inhibitors, Other Drug Classes

2) By Mode of Administration: Topical, Injectable, Oral

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Emollients Or Moisturizers: Creams and Lotions, Ointments and Balms, Barrier Repair Creams

3) By IL-4 And PDE4 Inhibitors: Dupilumab (IL-4 Inhibitor), Apremilast (PDE4 Inhibitor)

4) By Calcineurin Inhibitors: Tacrolimus Ointment, Pimecrolimus Cream

5) By Other Drug Classes: Biologics, JAK Inhibitors

Which Upcoming Trends Are Expected To Influence The Atopic Dermatitis Market?

Leading companies in the atopic dermatitis market are concentrating on developing innovative therapies, such as IL-31 receptor antagonists, with the aim of alleviating chronic itch, enhancing control over skin symptoms, and diminishing systemic side effects compared to traditional corticosteroids or immunosuppressants. An IL-31 receptor antagonist operates by blocking the IL-31 signaling pathway, a pathway directly involved in the sensation of itch and inflammation, thereby offering a more targeted approach than broad immune suppression. For instance, in December 2024, Galderma, a Switzerland-based dermatology company, secured FDA approval for Nemluvio (nemolizumab), marking it as the first monoclonal antibody specifically designed to target the IL-31 receptor alpha to inhibit IL-31 signaling in moderate-to-severe atopic dermatitis. This therapy is administered via subcutaneous injection, where it binds to the IL-31 receptor to prevent activation by the IL-31 cytokine, and has demonstrated in clinical trials its ability to provide rapid relief from itch and significant improvement in skin symptoms when used alongside topical treatments.

Which Major Players Dominate The Atopic Dermatitis Market?

Major companies operating in the atopic dermatitis market are Sanofi SA, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma SA, Incyte Corporation, Bayer AG, Bausch Health Companies Inc., GlaxoSmithKline PLC, LEO Pharma A/S, Teva Pharmaceutical Industries Ltd., Allergan PLC, Menlo Therapeutics Inc., Johnson & Johnson, Merck & Co Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eisai Co. Ltd., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Limited

Read the full atopic dermatitis market report here:

https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

Which Region Is Forecast To Lead The Atopic Dermatitis Market In Terms Of Market Size?

North America was the largest region in the atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Atopic Dermatitis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8285&type=smp

Browse Through More Reports Similar to the Global Atopic Dermatitis Market 2026, By The Business Research Company

Plastic Pipes And Pipe Fittings Global Market Report

https://www.thebusinessresearchcompany.com/report/plastic-pipes-and-pipe-fittings-global-market-report

Hot Dip Galvanizing Global Market Report

https://www.thebusinessresearchcompany.com/report/hot-dip-galvanizing-global-market-report

Drill Pipe Global Market Report

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795